Table 11.
Sample Conc. (μg/ml) |
HCT-116 Cell viability % Inhibitory activity % |
IC50 |
HepG2 Cell viability % Inhibitory activity % |
IC50 |
MCF-7 Cell viability % Inhibitory activity % |
IC50 |
|||
---|---|---|---|---|---|---|---|---|---|
Stand. | Sample |
|
Stand. | Sample |
|
Stand. | Sample |
|
|
500 | 9.60 |
7.11 92.89 |
100 μg/ml |
17.48 |
19.71 80.29 |
155 μg/ml |
14.26 |
25.17 74.83 |
165 μg/ml |
250 | 17.28 |
28.12 71.88 |
29.45 |
37.82 62.18 |
17.64 |
43.69 56.31 |
|||
125 | 31.36 |
41.32 58.68 |
45.69 |
52 48 |
20.82 |
58.16 41.84 |
|||
62.5 | 44.45 |
65 35 |
55.95 |
75 25 |
41.96 |
80.44 19.56 |
|||
31. 5 | 58.64 |
80 20 |
71.33 |
86 14 |
49.40 |
92.21 7.79 |
|||
15.6 | 64.40 |
86 14 |
75.50 |
93.40 6.6 |
54.12 |
96.44 3.56 |
|||
3.9 | 69.34 |
91.61 8.39 |
78.92 |
98.81 1.19 |
60.21 |
99.10 0.9 |
|||
0 | 100 |
100 0 |
100 |
100 0 |
100 |
100 0 |